Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of ...

Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 billion by 2030 at a compound annual growth rate (CAGR) of 5.45%, reflecting ...

In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...

These corporate actions come as Vincerx Pharma, headquartered in San Mateo, California, continues to navigate the competitive pharmaceutical industry, with a focus on developing treatments in its ...

Stressing the need for the restoration of Weighted R&D Deduction (up to 200%), he noted that it would significantly boost ...

In a 2026 industry outlook interview, Laine Mello, Ecolab Life Sciences, explains how next-gen therapies, digitalization, and ...

As artificial intelligence continues to dominate conversations across life sciences, many companies are reaching an inflection point between experimentation and real-world impact. In a recent episode ...

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, ...